Clinical Trial Update: Novel Treatment for Syndromic Ichthyoses [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial for a novel treatment targeting syndromic ichthyoses has been withdrawn from the study registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Child Syndrome
• Conradi-hunermann Syndrome
• Smith-lemli-opitz Syndrome
• Syndromic Ichthyoses

Snippet

Sponsor: Northwestern University | Conditions: Syndromic Ichthyoses, CHILD Syndrome | Phase 2 | Status: WITHDRAWN